Goldman Sachs lifts Carl Zeiss Meditec voting rights to 5.58% from 5.27%

• Goldman Sachs raised its total voting rights stake in Carl Zeiss Meditec to 5.58% from 5.27% on Aug. 28.
• Voting rights from shares fell to 0.57% from 0.72%.
• Voting rights through instruments climbed to 5.01% from 4.55%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2393564_en) on September 03, 2026, and is solely responsible for the information contained therein.